Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by ORENSTEIN, W. A.
Right arrow Articles by FIUMARA, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ORENSTEIN, W. A.
Right arrow Articles by FIUMARA, N. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 124, No. 2: 290-298
Copyright © 1986 by The Johns Hopkins University School of Hygiene and Public Health


research-article

PREVALENCE OF RUBELLA ANTIBODIES IN MASSACHUSETTS SCHOOL CHILDREN

WALTER A. ORENSTEIN1, KENNETH L. HERRMANN2, PATRICIA HOLMGREEN1, ROGER BERNIER1, KENNETH J. BART1, DONALD L. EDDINS1 and NICHOLAS J. FIUMARA3

1 Division of Immunization, Centers for Disease Control Atlanta, GA
2 Division of Viral Diseases, Centers for Disease Control Atlanta, GA
3 Massachusetts Department of Public Health Boston, MA

Reprint requests to Technical Information Services, Center for Prevention Services, Centers for Disease Control, Atlanta, GA 30333

In 1982, 1,871 (79%) of 2,388 eligible 6th, 10th and 12th grade students in Massachusetts participated in a statewide serosurvey for rubella antibodies. Sera were screened at the Centers for Disease Control (CDC) by a reference hemag glutination inhibition assay at 1:8, equivalent to approximately 15 International Units (IU)/ml. Sera negative by the CDC hemagglutinatlon inhibition assay were retested using an enzyme immunoassay, a passive hemagglutinatlon assay, and a commercial hemagglutination inhibition test. The approximate screening levels were 10 IU/ml, 7.5 IU/ml, and 5 IU/ml, respectively. Overall seroprevalence levels varied from 76.4% screening at 15 IU to 93.1% including seropositives from any of the tests. Persons with a school record of vaccination had significantly higher seroprevalance levels than persons without records. However, only 78.3% of persons with a record had antibody ≥15IU compared wIth 60.0% without records; considering any detectable antibody, the comparison is 95.6% versus 71.4%. The low titers in vaccinees appeared to be due to a falloff of antibody with time since vaccination. Of students with a single vaccination noted in the record with exact dates, 92.3% who were vaccinated 0–4 years prior to the study had antibody at 15 IU compared with <78% of students with antibody who were vaccinated five or more years prior to the study. In contrast, using more sensitive assays, there was no significant decline in seroprevalence with time since vaccination. Revaccinatlon studies and epidemiologic data suggest that almost all persons with detectable antibody whether above or below 15 IU/ml are immune to rubella. Thus, immunity levels in Massachusetts schoolchildren in the 6th, 10th, and 12th grades are probably in excess of 90%.

medical records; rubella; rubella vaccine; serology; vaccination


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
AJPHHome page
M. C. Danovaro-Holliday, E. R. Gordon, C. Woernle, G. H. Higginbotham, R. H. Judy, J. P. Icenogle, and S. E. Reef
Identifying Risk Factors for Rubella Susceptibility in a Population at Risk in the United States
Am J Public Health, February 1, 2003; 93(2): 289 - 291.
[Full Text] [PDF]


Home page
JAMAHome page
S. Y. Chu, R. H. Bernier, J. A. Stewart, K. L. Herrmann, J. R. Greenspan, A. K. Henderson, and A. P. Liang
Rubella Antibody Persistence After Immunization: Sixteen-Year Follow-up in the Hawaiian Islands
JAMA, June 3, 1988; 259(21): 3133 - 3136.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.